Driehaus Capital Management’s Eli Lilly LLY Stock Holding History

Driehaus Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.07M	Buy	1,168 +345	+42%	+$350K	0.01%	317
2025 Q4	$884K	Buy	823 +349	+74%	+$334K	0.01%	357
2025 Q3	$362K	Sell	474 -1,167	-71%	-$868K	﹤0.01%	411
2025 Q2	$1.28M	Sell	1,641 -34	-2%	-$26.4K	0.01%	350
2025 Q1	$1.38M	Buy	1,675 +708	+73%	+$589K	0.01%	336
2024 Q4	$747K	Sell	967 -223	-19%	-$185K	0.01%	341
2024 Q3	$1.05M	Sell	1,190 -445	-27%	-$400K	0.01%	319
2024 Q2	$1.48M	Buy	1,635 +793	+94%	+$634K	0.01%	294
2024 Q1	$655K	Buy	842 +238	+39%	+$169K	0.01%	333
2023 Q4	$352K	Hold	604	–	–	﹤0.01%	350
2023 Q3	$324K	Sell	604 -918	-60%	-$473K	﹤0.01%	363
2023 Q2	$714K	Buy	+1,522	New	+$638K	0.01%	324
2018 Q2	–	Sell	-4,076	Closed	-$315K	–	513
2018 Q1	$315K	Buy	+4,076	New	+$328K	0.01%	436
2016 Q1	–	Sell	-131,222	Closed	-$11.1M	–	601
2015 Q4	$11.1M	Buy	+131,222	New	+$10.9M	0.37%	63

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Driehaus Capital Management's LLY Position: Q1 2026 in Review

Driehaus Capital Management increased its Eli Lilly (LLY) stake by 42% in Q1 2026, buying an estimated $350K and bringing the position to 1,168 shares worth $1.07M. The position accounts for 0.01% of the portfolio, ranked #317.

Driehaus Capital Management first reported a position in LLY in Q4 2015 and has held it in 14 quarters since. The position peaked at $11.1M in Q4 2015. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Driehaus Capital Management held 1,168 shares of Eli Lilly worth $1.07M as of Q1 2026.
Driehaus Capital Management bought 345 Eli Lilly shares in Q1 2026, an estimated $350K.
Eli Lilly made up 0.01% of Driehaus Capital Management's portfolio in Q1 2026, its #317 holding.
Driehaus Capital Management first reported a position in Eli Lilly in Q4 2015 and has held it in 14 quarters since.
Driehaus Capital Management's Eli Lilly position peaked at $11.1M in Q4 2015.
4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.